NLGN1 and Alzheimer disease: In order to investigate Nlgn1 after shedding from the postsynaptic membrane, we analysed CSF samples from clinically diagnosed AD patients (n = 43) and Ctrl subjects (n = 42) by Western blot using the same antibodies as in the study of brain homogenates (Fig. 5).